ID
IDEAYA Biosciences, Inc.
IDYA · NASDAQ
$37.73 +0.05% (+$0.02)
1M +3.07%
Market Cap $3.62B
P/E Ratio -
Div. Yield -
ROE 16.47%
Bulios Fair Price
$31.25
17.2% downside
Trenutna cena
$37.73
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica IDYA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
33 /100
Expensive P/B 3.02x
P/S 15.44x
PEG N/A
Growth
100 /100
Growing Book val. growth 43.05%
Rev. growth 62.54%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 81.16%
Op. margin 92.66%
Gross margin 13.32%
Quality
2 /100
Poor Asset turnover 0.18x
ROA 13.36%
ROIC 17.66%
Debt
100 /100
Low Current ratio 10.45x
Debt/Equity 0.02x
Net debt/EBITDA N/A
Stability
17 /100
Unstable Profitable years 0
EPS volatility 69.38%
Beta -0.09x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o IDYA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Yujiro S. Hata
Employees
145
Headquarters
South San Francisco
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report